Categories: Health

Director/PDMR Shareholding

 | Source: DXS International PLC

DXS INTERNATIONAL PLC

(AQSE: DXSP)

Notification of Director / PDMR Dealing

DXS INTERNATIONAL PLC

The Board of DXS International plc (the “Company” or “DXSP), the AQSE Growth Market quoted clinical decision support developer and supplier of clinical decision support systems, has received notification that on 30 January, Mr Bob Sutcliffe, the Chairman, purchased 15,000 Ordinary Shares in the Company at a price of 2.9p per share.

Following this transaction Mr Sutcliffe and his wife’s interest in DXS Ordinary Shares is 1,253,756 Ordinary Shares representing 1.96% of the issued share capital of the Company.

1 Details of the person discharging managerial responsibilities / person closely associated
a) Name Mr. Robert Sutcliffe
2 Reason for the notification
a) Position/status Chairman
b) Initial notification /Amendment Initial
3 Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a) Name DXS INTERNATIONAL PLC
b) LEI 2138001R1KEUWTXEVJ44
4 Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a) Description of the financial instrument, type of instrument Ordinary Shares of 0.33p each
Identification code ISIN GB00B2Q6HZ92
b) Nature of the transaction Purchase of shares
c) Price(s) and volume(s)
Price(s) Volume(s)
2.9p 15,000
d) Aggregated information
– Aggregated volume
– Price
e) Date of the transaction 30 January 2025
f) Place of the transaction Aquis Stock Exchange

The Directors of DXS International plc accept responsibility for this announcement.

Contacts:

David Immelman
DXS International plc
www.dxs-systems.com
01252 719800
AQSE Corporate Broker and Corporate Advisor
Hybridan LLP
Claire Louise Noyce
020 3764 2341

Notes to Editors

About DXS:
DXS International presents up to date treatment guidelines and recommendations, from Clinical Commissioning Groups and other trusted NHS sources, to doctors, nurses and pharmacists in their workflow and during the patient consultation. This effective clinical decision support ultimately translates to improved healthcare outcomes delivered more cost effectively and which should significantly contribute towards the NHS achieving its projected efficiency savings.

GlobeNews Wire

Recent Posts

LOYALTY PROGRAMS AND THE CURRENCY EFFECT

Global Experts Reveal the Hidden Mechanics of Loyalty Currencies and How Businesses Can Profit from…

1 hour ago

3CLogic named Thirdera 2024 Partner of the Year

3CLogic selected as partner of the year by Thirdera, a Cognizant company, in recognition of…

1 hour ago

Axiad Applauded by Frost & Sullivan for Providing Phishing-resistant Authentication with PKI-based Authentication

Axiad's PKI-based authentication enables scalability and flexibility in large-scale enterprise environments, elevates user experience and…

1 hour ago

Exterro Wins ‘Best GRC Platform’ Award at FutureCrime Summit 2025

Award Win Validates the Benefits of Approaching Data Risks and Compliance Challenges Holistically NEW DELHI,…

1 hour ago

Global Sourcing Fair Vietnam 2025 – More Suppliers, More Opportunities, More Business

HO CHI MINH CITY, Vietnam, Feb. 26, 2025 /PRNewswire/ -- Organized by Global Sources, the…

2 hours ago

Party at Home with the year’s Biggest Award Shows on Toshiba TV

HONG KONG, Feb. 26, 2025 /PRNewswire/ -- From the renowned music celebration's dazzling performances to…

2 hours ago